IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.

Juergen FREVERT 医师

博士研究员

德国

传记

Dr Jürgen Frevert is Head of Botulinum Toxin Research at Merz Pharmaceuticals GmbH, in Potsdam, Germany.Between 1995 and 2006, Dr Frevert was Project Manager for biochemical projects and later Chief Scientific Officer of BioteCon Therapeutics GmbH, and during this time he was responsible for the development of NT101/NT201 (licensed as Bocouture®).Dr Frevert is trained in chemistry and biochemistry and has published articles in the scientific and medical literature.